Ironwood Pharmaceuticals (IRWD) Capital Leases (2010 - 2018)

Ironwood Pharmaceuticals has disclosed Capital Leases across 9 years of filings, most recently posting $158000.0 for Q4 2018.

• Capital Leases for Q4 2018 came in at $158000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $158000.0 (changed N/A YoY), and the FY2018 annual result was $158000.0, changed N/A from the prior year.
• Capital Leases came in at $158000.0 for Q4 2018 at Ironwood Pharmaceuticals, up from $21000.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $3.2 million in Q2 2014 to a low of $21000.0 in Q1 2017.
• The 5-year median for Capital Leases is $687000.0 (2015), against an average of $1.3 million.
• Across the five-year window, Capital Leases surged 1494.95% in 2014 and sank 91.7% in 2017, its largest moves.
• Ironwood Pharmaceuticals' Capital Leases stood at $2.6 million in 2014, then plunged by 88.1% to $306000.0 in 2015, then tumbled by 73.2% to $82000.0 in 2016, then sank by 74.39% to $21000.0 in 2017, then jumped by 652.38% to $158000.0 in 2018.
• The last three Capital Leases figures came in at $158000.0 (Q4 2018), $21000.0 (Q1 2017), and $82000.0 (Q4 2016), per Business Quant data.